UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Journal of antimicrobial chemotherapy, 2015-05, Vol.70 (5), p.1466-1472

2015

Link zum Volltext

Verfügbarkeit prüfen

Review of trials currently testing treatment and prevention of COVID-19

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.988-998

2020

Link zum Volltext

Verfügbarkeit prüfen

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Journal of antimicrobial chemotherapy, 2020-08, Vol.75 (8), p.2334-2343

2020

Link zum Volltext

Verfügbarkeit prüfen

Reconstructing social interactions using an unreliable wireless sensor network

Computer communications, 2011-04, Vol.34 (5), p.609-618

2011

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3611-3618

2020

Link zum Volltext

Verfügbarkeit prüfen

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

British journal of cancer, 2013-09, Vol.109 (5), p.1147-1156

2013

Link zum Volltext

Verfügbarkeit prüfen

Role of modelling and simulation in Phase I drug development

European journal of pharmaceutical sciences, 2001-05, Vol.13 (2), p.115-122

2001

Link zum Volltext

Verfügbarkeit prüfen

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Computer methods and programs in biomedicine, 2001-05, Vol.65 (2), p.141-151

2001

Link zum Volltext

Verfügbarkeit prüfen

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

Clinical microbiology and infection, 2014-12, Vol.20 (12), p.O1035-O1041

2014

Link zum Volltext

Verfügbarkeit prüfen

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Link zum Volltext

Verfügbarkeit prüfen

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

CPT: pharmacometrics and systems pharmacology, 2014-12, Vol.3 (12), p.1-4

Mentré, F

2014

Link zum Volltext

Verfügbarkeit prüfen

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

European journal of clinical pharmacology, 2019-04, Vol.75 (4), p.519-528

2019

Link zum Volltext

Verfügbarkeit prüfen

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

Clinical pharmacology and therapeutics, 2020, Vol.108 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients

Infectious diseases now (Online), 2023-02, Vol.53 (1), p.104625, Article 104625

2023

Link zum Volltext

Verfügbarkeit prüfen

Optimal design of a population pharmacodynamic experiment for ivabradine

Pharmaceutical research, 2001, Vol.18 (1), p.83-89

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.583-587

2003

Link zum Volltext

Verfügbarkeit prüfen

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

CPT: pharmacometrics and systems pharmacology, 2013-06, Vol.2 (6), p.1-2

2013

Link zum Volltext

Verfügbarkeit prüfen

Modelling approaches in dose finding clinical trial: Simulation-based study comparing predictive performances of model averaging and model selection

Journal of pharmacokinetics and pharmacodynamics, 2017, Vol.44, p.S16

2017

Link zum Volltext

Verfügbarkeit prüfen

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

CPT: pharmacometrics and systems pharmacology, 2014-04, Vol.3 (4), p.1-9

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of salivary amylase as a stress biomarker in pregnant patients

International journal of obstetric anesthesia, 2012-01, Vol.21 (1), p.35-39

2012

Link zum Volltext

Verfügbarkeit prüfen

Best Practices in Population Modeling Should Always Be Evolving

CPT: pharmacometrics and systems pharmacology, 2013-07, Vol.2 (7), p.1-2

2013

Link zum Volltext

Verfügbarkeit prüfen

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72, p.202401, Article 202401

2024

Link zum Volltext

Verfügbarkeit prüfen

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 194

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15

Review of trials currently testing treatment and prevention of COVID-19

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Reconstructing social interactions using an unreliable wireless sensor network

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

Role of modelling and simulation in Phase I drug development

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses

The ISoP Standards and Best Practices Committee

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2: Clin Pharmacol Ther

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients

Optimal design of a population pharmacodynamic experiment for ivabradine

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

Modelling approaches in dose finding clinical trial: Simulation-based study comparing predictive performances of model averaging and model selection

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

Assessment of salivary amylase as a stress biomarker in pregnant patients

Best Practices in Population Modeling Should Always Be Evolving

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Aktive Filter

Suchergebnisse filtern